Found 40 results
Author Title Type [ Year(Asc)]
Filters: Author is Wolff, M  [Clear All Filters]
2015
L. Baden, Liu, J., Li, H., Johnson, J., Walsh, S., Kleinjan, J., Engelson, B., Peter, L., Abbink, P., ,, Golden, K., Viani, K., Stachler, M., Chen, B., ,, Wolff, M., Loblein, H., Seaman, M., Dolin, R., and Barouch, D., “Induction of HIV-1-Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans”, J Infect Dis, vol. 211, pp. 518-528, 2015.
S. E. Frey, Bernstein, D. I., Brady, R. C., Keitel, W. A., Sahly, H. E., Rouphael, N. G., Mulligan, M. J., Atmar, R. L., Edupuganti, S., Patel, S. M., Dickey, M., Graham, I., Anderson, E. L., Noah, D. L., Hill, H., Wolff, M., and Belshe, R. B., “Phase II Trial in Adults of Concurrent or Sequential 2009 Pandemic H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations”, Vaccine, vol. 33, pp. 163-173, 2015.
2014
K. L. Kotloff, Halasa, N. B., Harrison, C. J., Englund, J. A., Walter, E. B., King, J. C., Creech, C. B., Healy, S. A., Dolor, R. J., Stephens, I., Edwards, K. M., Noah, D. L., Hill, H., and Wolff, M., “Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children”, Pediatr Infect Dis J, vol. 33, pp. 865-871, 2014.
L. R. Baden, ,, Seaman, M. S., Johnson, J. A., Tucker, R. P., Kleinjan, J. A., Gothing, J. A., Engelson, B. A., Carey, B. R., Oza, A., Bajimaya, S., Peter, L., Bleckwehl, C., Abbink, P., Pau, M. G., Weijtens, M., Kunchai, M., Swann, E. M., Wolff, M., Dolin, R., and Barouch, D. H., “First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002)”, J Infect Dis, vol. 210, pp. 1052-1061, 2014.
S. T. Callahan, Wolff, M., Hill, H. R., Edwards, K. M., Vaccine, N. I. A. I. D., and Group, T. Evaluation, “Impact of Body Mass Index on Immunogenicity of Pandemic H1N1 Vaccine in Children and Adults”, J Infect Dis, vol. 210, pp. 1270-1274, 2014.
B. Rivoire, Groathouse, N., TerLouw, S., K Neupane, D., Ranjit, C., B Sapkota, R., Khadge, S., Kunwar, C., Macdonald, M., Hawksworth, R., Thapa, M., Hagge, D., Tibbals, M., Smith, C., Dube, T., She, D., Wolff, M., ,, Sizemore, C., and Brennan, P., “Safety and Efficacy Assessment of Two New Leprosy Skin Test Antigens: Randomized Double Blind Clinical Study”, PLOS Neglected Tropical Diseases, vol. 8, p. e2811, 2014.
2013
L. R. Baden, ,, Seaman, M. S., Tucker, R. P., Krause, K. H., Patel, A., Johnson, J. A., Kleinjan, J., Yanosick, K. E., Perry, J., Zablowsky, E., Abbink, P., Peter, L., Iampietro, M. J., Cheung, A., Pau, M. G., Weijtens, M., Goudsmit, J., Swann, E., Wolff, M., Loblein, H., and Dolin, R., “First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)”, J Infect Dis, vol. 207, pp. 240-247, 2013.
A. C. Seña, Wolff, M., Behets, F., Van Damme, K., and , “Response to Therapy Following Retreatment of Serofast Early Syphilis Patients with Benzathine Penicillin”, Clin Infect Dis, vol. 56, pp. 420-422, 2013.
2012
W. H. Chen, Winokur, P. L., Edwards, K. M., Jackson, L. A., Wald, A., Walter, E. B., Noah, D. L., Wolff, M., Kotloff, K. L., Chua, J. V., Hutter, J., Stephens, I., Stapleton, J., Meier, J., Callahan, S. T., Creech, C. B., Halasa, N. B., Johnston, C., Dolor, R. J., Schmader, K. E., Woods, C. W., and Hill, H., “Phase 2 Assessment of the Safety and Immunogenicity of Two Inactivated Pandemic Monovalent H1N1 Vaccines in Adults as a Component of the U.S. Pandemic Preparedness Plan in 2009”, Vaccine, vol. 13, pp. 4240-4248, 2012.
K. M. Holman, Wolff, M., Seña, A. C., Martin, D. H., Behets, F., Van Damme, K., Leone, P. A., McNeil, L., Gehrig, M. L., and Hook, E. W. 3rd, “Rapid Plasma Reagin Titer Variation in the 2 Weeks After Syphilis Therapy”, Sex Transm Dis, vol. 39, pp. 645-647, 2012.
S. E. Frey, Bernstein, D. I., Gerber, M. A., Keyserling, H. L., Munoz, F. M., Winokur, P. L., Turley, C. B., Rupp, R. E., Hill, H., Wolff, M., Noah, D. L., Ross, A. C., Cress, G., and Belshe, R. B., “Safety and Immune Responses in Children After Concurrent or Sequential 2009 H1N1 and 2009-2010 Seasonal Trivalent Influenza Vaccinations”, J Infect Dis, vol. 206, pp. 828-837, 2012.
2011
R. W. Frenck, Jr, Belshe, R., Brady, R. C., Winokur, P. L., Campbell, J. D., Treanor, J., Hay, C. M., Dekker, C. L., Walter, Jr., E. B., TR, C., KM, E., Hill, H., Wolff, M., Leduc, T., and Tornieporth, N., “Comparison of the Immunogenicity and Safety of a Split-Virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal and Intramuscular Route in Healthy Adults”, Vaccine, vol. 29, pp. 5666-5674, 2011.
L. A. Jackson, Patel, S. M., Swamy, G. K., Frey, S. E., Creech, C. B., Munoz, F. M., Artal, R., Keitel, W. A., Noah, D. L., Petrie, C. R., Wolff, M., and Edwards, K. M., “Immunogenicity of an Inactivated Monovalent 2009 H1N1 Influenza Vaccine in Pregnant Women”, J Infect Dis, vol. 204, pp. 854-863, 2011.
A. C. Seña, Wolff, M., Martin, D. H., Behets, F., Van Damme, K., Leone, P. A., Langley, C., McNeil, L., and Hook, E. W., “Predictors of Serological Cure and Serofast State After Treatment in HIV-Negative Persons With Early Syphilis”, Clin Infect Dis, vol. 11, pp. 1092-1099, 2011.
2010
E. Hook, Behets, F., Van Damme, K., Ravelomanana, N., Leone, P., Seña, A., Martin, D., Langley, C., McNeil, L., and Wolff, M., “A Phase III Equivalence Trial of Azithromycin vs. Benzathine Penicillin for Treatment of Early Syphilis”, J Infect Dis, vol. 201, pp. 1729-1735, 2010.
S. Frey, Houghton, M., Coates, S., Abrignani, S., Chien, D., Rosa, D., Pileri, P., Ray, R., Di Bisceglie, A., Rinella, P., Hill, H., Wolff, M., Schultze, V., Han, J., Scharschmidt, B., and Belshe, R., “Safety and Immunogenicity of HCV E1E2 Vaccine Adjuvanted with MF59 Administered to Healthy Adults”, Vaccine, vol. 28, pp. 6367-6373, 2010.
2008
N. A. Goji, Nolan, C., Hill, H., Wolff, M., Noah, D. L., Williams, T. B., Rowe, T., and Treanor, J. J., “Immune Responses of Healthy Subjects to a Single Dose of Intramuscular Inactivated Influenza A/Vietnam/1203/2004 (H5N1) Vaccine After Priming with an Antigenic Variant”, J Infec Dis, vol. 198, pp. 635-641, 2008.
2005
M. Laassri, Lottenbach, K., Belshe, R., Wolff, M., Rennels, M., Plotkin, S., and Chumakov, K., “Effect of Different Vaccination Schedules on Excretion of Oral Poliovirus Vaccine Strains”, J Infect Dis, vol. 192, pp. 2092-2098, 2005.
2003
P. B. Gilbert, Chiu, Y. - L., Allen, M., Lawrence, D. N., Chapdu, C., Israel, H., Holman, D., Keefer, M. C., Wolff, M., and Frey, S. E., “Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials.”, Vaccine, vol. 21, no. 21-22, pp. 2933-47, 2003.
P. B. Gilbert, Chiu, Y. L., Allen, M., Lawrence, D. N., Chapdu, C., Israel, H., Holman, D., Keefer, M. C., Wolff, M., Frey, S. E., and Network, N. I. A. I. D. H. I. V. Vaccin, “Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials”, Vaccine, vol. 21-22, pp. 2933-2947, 2003.
2002
J. Treanor, Keitel, W., Belshe, R., Campbell, J., Schiff, G., Zangwill, K., Wolff, M., Klimov, A., Levandowski, R., and Lambert, L., “Evaluation of a Single Dose of Half Strength Inactivated Influenza Vaccine in Healthy Adults”, Vaccine, vol. 20, pp. 1099-1105, 2002.
2001
P. C. Rowe, Calkins, H., DeBusk, K., McKenzie, R., Anand, R., Sharma, G., Cuccherini, B. A., Soto, N., Hohman, P., Snader, S., Lucas, K. E., Wolff, M., and Straus, S. E., “Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial.”, JAMA, vol. 285, no. 1, pp. 52-9, 2001.
J. J. Treanor, Wilkinson, B. E., Masseoud, F., Hu-Primmer, J., Battaglia, R., O’Brien, D., Wolff, M., Rabinovich, G., Blackwelder, W., and Katz, J. M., “Safety and Immunogenicity of a Recombinant Hemagglutinin Vaccine for H5 Influenza in Humans”, Vaccine, vol. 19, pp. 1732-1737, 2001.
J. J. Treanor, Wilkinson, B. E., Masseoud, F., Hu-Primmer, J., Battaglia, R., O'Brien, D., Wolff, M., Rabinovich, G., Blackwelder, W., and Katz, J. M., “Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans.”, Vaccine, vol. 19, no. 13-14, pp. 1732-7, 2001.
2000
J. C. King, Treanor, J., Fast, P. E., Wolff, M., Yan, L., Iacuzio, D., Readmond, B., O'Brien, D., Mallon, K., Highsmith, W. E., Lambert, J. S., and Belshe, R. B., “Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.”, J Infect Dis, vol. 181, no. 2, pp. 725-8, 2000.